Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Feb 15, 2024

BUY
$2.72 - $4.61 $16,556 - $28,061
6,087 New
6,087 $23,000
Q2 2022

Feb 14, 2024

BUY
$2.71 - $7.12 $16,495 - $43,339
6,087 New
6,087 $16,000
Q2 2022

Jul 26, 2022

BUY
$2.71 - $7.12 $16,495 - $43,339
6,087 New
6,087 $16,000
Q1 2020

May 04, 2020

SELL
$5.57 - $10.76 $331,843 - $641,048
-59,577 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$9.63 - $13.09 $303,614 - $412,701
31,528 Added 112.4%
59,577 $0
Q4 2018

Jan 31, 2019

SELL
$10.53 - $15.54 $85,177 - $125,703
-8,089 Reduced 22.38%
28,049 $327,000
Q3 2018

Nov 14, 2018

SELL
$15.25 - $17.72 $1.18 Million - $1.37 Million
-77,371 Reduced 68.16%
36,138 $0
Q4 2017

Feb 07, 2018

BUY
$13.44 - $22.81 $336,094 - $570,409
25,007 Added 28.26%
113,509 $0
Q3 2017

Nov 13, 2017

BUY
$19.97 - $22.74 $1.77 Million - $2.01 Million
88,502
88,502 $0

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $285M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.